Cancer gene therapy using mesenchymal stem cells

@article{Uchibori2014CancerGT,
  title={Cancer gene therapy using mesenchymal stem cells},
  author={R. Uchibori and T. Tsukahara and K. Ohmine and K. Ozawa},
  journal={International Journal of Hematology},
  year={2014},
  volume={99},
  pages={377-382}
}
Abstract Cellular and gene therapies represent promising treatment strategies at the frontier of medicine. Hematopoietic stem cells, lymphocytes, and mesenchymal stem cells (MSCs) can all serve as sources of cells for use in such therapies. Strategies for gene therapy are often based on those of cell therapy, and it is anticipated that some examples will be put to practical use in the near future. Given their ability to support hematopoiesis, MSCs may be useful for the enhancement of stem cell… Expand
Mesenchymal Stem Cells: vector for targeted cancer therapy
TLDR
The preeminent characteristics of MSCs and their influence ontumor cell growth and metastasis are discussed and may represent an encouraging platform for cancer treatment. Expand
Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer
TLDR
Tumour-homing ability of MSCs and their exosomes to tumour niches have made them as a promising vector for targeted delivery of therapeutic agents to tumours site, and they are likely as potent cellular vehicles. Expand
Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
TLDR
The advantages and challenges of nonviral vectors for MSC transfection are summarized and recent advances in the development of new nonViral vectors are discussed, which have provided promising strategies to overcome obstacles in the gene modulation of MSCs. Expand
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
TLDR
The current state of MSC-based therapeutic approaches for cancer is summarized, and the remaining questions, obstacles and risks, as well as novel developments such as M SC-derived nanoghosts are described. Expand
Mesenchymal stem cells: A new platform for targeting suicide genes in cancer
TLDR
The current state of knowledge about genetically modified MSCs that enable to co‐transduce a variety of therapeutic agents including suicide genes (i.e., cytosine deaminase, thymidine kinase) in order to exert potent anti‐carcinogenesis against various tumors growth is summarized. Expand
Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy
TLDR
By improving the loading of therapeutic agents into stem cells and enhancing their migratory ability and persistence, significant improvements in targeted cancer therapy may be achieved. Expand
Mini Review: Application of Human Mesenchymal Stem Cells in Gene and Stem Cells Therapy Era
TLDR
The current understanding of using MSCs or MSC-conditioned media as treatment for various diseases is reviewed, but it still requires further investigations on how M SCs respond to various microenvironments and how to isolate, purify and expand enough MCSs ex vivo. Expand
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
TLDR
It is shown that chemotherapy-educated mesenchymal stem cells (MSC) promote therapy resistance via cross-talk with tumor-initiating cells (TIC), a resistant tumor cell subset that initiates tumorigenesis and metastasis and a novel drug delivery system to target TICs and overcome this resistance. Expand
Engineering mesenchymal stem cells for enhanced cancer therapy
TLDR
The work to engineer mesenchymal stem cells to tackle three issues and develop a system that can increase the efficacy of glioblastoma treatment is detailed. Expand
The Role of Mesenchymal Stem Cells in Promoting Ovarian Cancer Growth and Spread
TLDR
The central hypothesis is that MSC1 will home to the ovarian tumor microenvironment and shift the balance from a tumor promoting stroma to a tumor eradicating one that attenuates tumor growth and spread by influencing the secretion of defined soluble factors and extracellular matrix proteins as well as modifying the host immune response. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis
TLDR
It has been confirmed that MSC promote hematopoietic cell engraftment and immune recovery after allogeneic hematoplastic stem cell transplantation, probably through the provision of cytokines, matrix proteins, and cell-to-cell contacts. Expand
Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.
TLDR
The novel prospects of MSC-based tumor therapy, which appears to be a promising approach, are highlighted, based on recent findings demonstrating that MSCs share many characteristics with pericytes and that implanted M SCs localize primarily to perivascular niches within tumors, which might have therapeutic implications. Expand
Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
TLDR
The potential of genetically modified MSC, constitutively expressing interferon (IFN)-β, in an immunocompetent mouse model of prostate cancer lung metastasis is evaluated and a significant reduction in tumor volume in lungs is indicated following IFN-β-expressing MSC therapy. Expand
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
TLDR
MSC derived from adipose tissue as suitable delivery vehicles for prodrug converting gene and show their utility for a personalized cell-based targeted cancer gene therapy are characterized. Expand
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
TLDR
It is demonstrated that, for the purpose of anticancer therapy, bone marrow-derived mesenchymal stem cells (MSCs) can produce biological agents locally at tumor sites and that the tumor microenvironment preferentially promotes the engraftment of MSCs as compared with other tissues. Expand
Targeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells
TLDR
The tropism of mouse MSCs to tumor cells in vitro and multiple tumor tissues in the lung after i.v. injection of green fluorescent protein‐positive MSCS in vivo is demonstrated and suggests that MSC's can be used as a vehicle for introducing biological agents into multiple lung tumor tissues. Expand
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
TLDR
It is demonstrated that MSC-delivered recombinant TRAIL has profound anti-tumor effects in vivo and forms the basis for developing stem cell-based therapies for different cancers. Expand
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
TLDR
Injected MSC-IFN-beta cells suppressed the growth of pulmonary metastases, presumably through the local production of IFN- beta in the tumor microenvironment, and may be an effective platform for the targeted delivery of therapeutic proteins to cancer sites. Expand
Mesenchymal stem cells and their potential as cardiac therapeutics.
TLDR
HMSCs isolated from adult bone marrow provide an excellent model for development of stem cell therapeutics, and their potential use in the cardiovascular system is currently under investigation in the laboratory and clinical settings. Expand
Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
TLDR
In vivo efficacy experiments showed that intratumoral injection of engineered UCB-MSCs (MSCs-stTRAIL) significantly inhibited tumor growth and prolonged the survival of glioma-bearing mice compared with controls, suggesting that human UCB -MSCs have potential use as effective delivery vehicles for therapeutic genes in the treatment of intracranialglioma. Expand
...
1
2
3
4
5
...